Hexagon

Hexagon Bio

This biopharmaceutical company develops novel cytotoxic payloads for antibody-drug conjugates to treat cancer and infectious diseases for pharmaceutical and healthcare organisations.

LiliumX

This biotechnology company develops a discovery platform and bispecific antibody-drug conjugates for the treatment of cancer and other complex diseases.

Lytica Therapeutics

This biotechnology company develops peptide-based antibody-drug conjugates to treat oncology and infectious disease patients.

Alphina Therapeutics

This biotechnology company develops antibody-drug conjugates with novel payloads to treat solid tumours for healthcare providers and cancer patients.

Heidelberg Pharma AG

This biopharmaceutical company develops antibody-drug conjugates for oncology patients using proprietary toxin technology to target and eliminate cancer cells.

HDAX Therapeutics

This biotechnology company develops small molecule inhibitors targeting the HDAC6 protein to treat patients with neuropathies, heart failure and various cancer conditions.

Qurient

This clinical-stage biotechnology company develops small-molecule therapeutics and antibody-drug conjugates for patients with cancer and infectious diseases.

Catena Bio

This biotechnology firm develops protein conjugation technology and multi-payload therapeutic conjugates for biopharmaceutical companies to treat oncology and autoimmune diseases.